Corcept Therapeutics

Medical Director, Oncology

Corcept Therapeutics$261K — $307K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • MD required
  • Board eligible or certified in an internal medicine subspecialty required; oncology/hematology board certification/eligibility preferred
  • 2+ years' clinical development experience in biotechnology/pharmaceutical industry or academic clinical trial unit
  • Proven track record of scholarly clinical research demonstrated by publications in top tier journals
  • Excellent communication and leadership skills in a cross-functional environment.

Responsibilities

  • Act as a clinical expert for internal teams and external contacts regarding therapeutic programs
  • Provide clinical and scientific leadership with training for Development and product Core Teams
  • Oversee operational staff, CROs, and clinical trial sites for oncology programs
  • Design clinical development plans for assigned molecules and support assessment through product core teams
  • Implement clinical studies from Phase I through Phase III for drug candidates
  • Establish relationships with external oncology experts and principal investigators
  • Approve scientific methods for clinical protocols, data collection, and reporting

Benefits

  • Collaborative work environment with experts in oncology
  • Opportunity to shape clinical development strategy for growing pipeline
  • Exposure to innovative oncology programs and late-stage trials
  • Potential for meaningful contributions to patient treatment options
Full Job Description
Building on the success of our Phase 3 ROSELLA clinical trial, Corcept's Oncology Clinical Development team is entering an exciting period of growth. We are seeking a Medical Director, Oncology to play a pivotal role in shaping clinical development strategy and advancing innovative oncology programs from early development through late-stage trials. This is an opportunity to bring your scientific and clinical expertise to a growing pipeline, collaborate with leading investigators and cross-functional teams, and help translate promising science into meaningful new treatment options for patients.

Responsibilities:
  • Act as clinical expert for both internal Company team members and for external contacts related to the assigned therapeutic programs
  • Provide clinical and scientific leadership including training and ongoing input, to members of the Development and product Core Teams on issues related to the therapeutic field
  • Provide medical oversight for Company operational staff, CROs and clinical trial sites in areas related to the oncology programs
  • Design the clinical development plan for indications relevant to assigned molecules programs and support the assessment of the development plans through the cross-functional product core team
  • Design, develop and implement clinical studies for the applicable drug candidate, from Phase I through Phase III
  • Establish relationships with external experts in the scientific oncology areas, including principal investigators and opinion leaders, to facilitate scientific excellence in clinical trials research
  • Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems and final reports
  • Participate in the writing and review of clinical protocols, investigator brochures, clinical study reports, publications and other documents
  • Deliver timely and high quality clinical data
  • Provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee
  • Participate in appropriate regulatory discussion and activities, including the filing of IND's, CTXs, NDA/MAAs, throughout the development cycle
  • Participate in clinical study report conceptualization, development and writing for global regulatory submissions
  • Other duties as assigned

Preferred Skills, Qualifications and Technical Proficiencies:
  • Candidates must be excellent communicators with proven leadership skills and the ability to successfully interact in a busy cross functional environment
  • Ability to establish and maintain a team "sense of urgency" around timelines

Preferred Education and Experience:
  • MD required
  • Board eligible or certified in an internal medicine subspecialty required; oncology/hematology board certification/eligibility preferred
  • 2+ years' clinical development experience in the biotechnology/pharmaceutical industry or an academic clinical trial unit
  • A proven track record of scholarly clinical research demonstrated by publications in top tier journals

The pay range that the Company reasonably expects to pay for this headquarters-based position is $261,400 - $307,600; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

About Corcept Therapeutics

Corcept Therapeutics is a commercial-stage pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders. The company's lead product, Korlym, is a cortisol receptor blocker that modulates the effects of cortisol, a hormone produced by the adrenal gland. Korlym is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Cushing's syndrome who have type 2 diabetes or glucose intolerance. The company is also developing other cortisol modulators, including CORT125134, which is in Phase II clinical trials for the treatment of patients with Cushing's syndrome and solid-tumor cancers. Corcept Therapeutics was founded in 1998 and is headquartered in Menlo Park, California.
Learn more about Corcept Therapeutics
Size
238 employees
Market Cap
$2.1 billion
Industry
Net Income
$106 million
Founded
1998
5 Year Trend
+35.1%
Revenue
$353.8 million
NASDAQ

Similar Jobs

More Jobs at Corcept Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Medical Director, Oncology jobs: